Strategic Incubation Partners - Investor Profile and Portfolio

Provider of payment platforms marketing solutions and startup investment services. The business maintains a platform for online and physical payment processing, develops marketing and digital business solutions, and operates an investment program to support and cultivate technology startups.

REGiMMUNE develops therapeutics for immune diseases using targeted immunomodulators. Its proprietary platform reVax is designed to enable target-specific immunosuppression by inducing immune regulatory cells. Its lead candidate is a liposomal formulation of alpha-GalCer, which is in phase II trials for graft vs host disease (GvHD). In addition, the company has another candidate in early studies for Type I diabetes.

Papiresu is an online retailer of e-books. It sells e-books in categories such as romantic novels, horror, light novel, harlequin novel, Way of life & culture, hobby & lifestyle, trivia, entertainment, Its mobile application is available in iOS and android store. The books once bought can be stored in the app. It has rental and membership service too. The company also rents books.

ORTHOREBIRTH developed ReBOSSIS which is a cottony type, synthetic bone-void-filling material. The product has properties such as Handling Ability, Moldability, Fluid Absorption & Retention, Osteogenic Potential, and Bioresorbability. The blood has to be injected into the ReBOSSIS, mixed well and attached to the affected part of the bone. The Major Investors mentioned by the company are Innovation Engine Inc., Yasuda Enterprise Development Co.,Ltd., Mitsubishi UFJ Capital Co.,Ltd.